Membrane Transporters-Ion Channels

Items 401-450 of 2532

Page
per page
Set Descending Direction
Catalog No.
Product Name
Application
Product Information
Citations
  1. P-glycoprotein inhibitor

    Encequidar (HM30181; HM30181A) is a potent and selective inhibitor of P-glycoprotein.
  2. phenylalkylamine calcium antagonist

    Gallopamil (Methoxyverapamil), a methoxy derivative of Verapamil, is a phenylalkylamine calcium antagonist.
  3. Serotonin reuptake inhibitor (SSRI)

    Escitalopram is a selective serotonin reuptake inhibitor (SSRI) with Ki of 0.89 nM.
  4. mitoKATP channels

    BMS-191095 is an activators of mitochondrial ATP-sensitive potassium (mitoKATP) channels.
  5. KATP activator

    Levcromakalim ((-)-Cromakalim) is an ATP-sensitive K+ channel (KATP) activator.
  6. Amiodarone is an antiarrhythmic drug for inhibition of ATP-sensitive potassium channel with an IC50 of 19.1 μM.

  7. Sodium Channel Nav1.7 inhibitor

    Funapide (TV 45070; XEN402) is a potent Sodium Channel Nav1.7 inhibitor.
  8. H+/K+-ATPase inhibitor

    Picoprazole is a specific inhibitor of H+/K+-ATPase with IC50 of 3.1??0.4 μM.
  9. NHE1 inhibitor

    BI-9627 is a sodium-hydrogen exchanger isoform 1 (NHE1) inhibitor with an EC50 of 31 nM.
  10. Piezo1 agonist

    Yoda 1 is a Piezo1 agonist. Yoda 1 activates purified Piezo1 channels.
  11. AMPAR agonist

    (S)-(-)-5-Fluorowillardiine is a potent and specific AMPAR agonist.
  12. hERG potassium channel inhibitor

    Cisapride(R 51619) is a nonselective 5-HT4 receptor agonist, it is also a potent hERG potassium channel inhibitor.
  13. T-type Ca2+ channel antagonist

    TTA-Q6 is a selective T-type Ca2+ channel antagonist, used in the neurological disease.
  14. potassium channel inhibitor

    VU591 is a potent, selective renal outer medullary potassium channel (ROMK or Kir1.1) inhibitor, with an IC50 of 0.24 μM.
  15. HCN channels inhibitor

    Zatebradine (UL-FS-49 (free base); UL-FS-49CL (free base)) is a potent inhibitor of hyperpolarization-activated cyclic nucleotide-gated (HCN) channels with an IC50 value of 1.96 ?M.
  16. Ionomycin calcium (SQ23377 calcium) is a potent, selective calcium ionophore and an antibiotic produced by Streptomyces conglobatus.
  17. Calcium channel blocker

    Levamlodipine besylate ((S)-Amlodipine besylate) is a powerful dihydropyridine calcium channel blocker, possessing vasodilation properties and used in the treatment of hypertension and angina.
  18. dual T-type and L-type calcium channel blocker

    Efonidipine Hcl (NZ-105) is a dual T-type and L-type calcium channel blocker (CCB).
  19. CP-AMPA receptors antagonist

    Naspm trihydrochloride (1-Naphthylacetyl spermine trihydrochloride), a synthetic analogue of Joro spider toxin, is a calcium permeable AMPA (CP-AMPA) receptors antagonist.
  20. TRPP3 channel inhibitor

    EIPA hydrochloride (L593754 hydrochloride) is a TRPP3 channel inhibitor with an IC50 of 10.5 μM. EIPA also inhibits Na+/H+-exchanger (NHE) and macropinocytosis.
  21. P-glycoprotein/MRP-1 modulator

    Biricodar (VX-710) is a modulator of P-glycoprotein and MRP-1; shows effective chemosensitizing activity in multidrug resistant cells.
  22. calcium antagonist

    Palonidipine is a calcium antagonist which is potential for the therapy of angina-pectoris and hypertension.
  23. TRPC4/TRPC5 antagonist

    HC-070 is an antagonist of TRPC4/TRPC5, with IC50s of 9.3 nM and 46 nM for hTRPC5 and hTRPC4 in cells, respectively.
  24. CFTR potentiator

    GLPG1837 is a potent and reversible CFTR potentiator, with EC50s of 3 nM and 339 nM for F508del and G551D CFTR, respectively.
  25. benzazepine calcium channel blocker

    SQ-31765 is a benzazepine calcium channel blocker.
  26. TRPC6 inhibitor

    DS88790512 is a potent, selective, and orally bioavailable TRPC6 inhibitor with an IC50 of 11 nM.
  27. TRPV1 antagonist

    AMG9810 is a selective and competitive vanilloid receptor 1 (TRPV1) antagonist with IC50 values of 24.5 and 85.6 nM for human and rat TRPV1, repectively.
  28. TREK-1 activator

    ML402 is a selective TREK-1 activator.
  29. potassium channel (non-GIRK1/X) activator

    VU0529331 is a modestly selective non-GIRK1-containing G protein-gated, inwardly-rectifying, potassium channel (non-GIRK1/X) activator, with EC50s of 5.1 ?M and 5.2 ?M for GIRK2 and GIRK1/2 in HEK293 cells, respectively, also effective on GIRK4 homomeric channel.
  30. NecroX-5 is a derivative of the NecroX, reduces intracellular calcium concentration, and possesses anti-inflammatory and anti-cancer activity.
  31. CRM1 inhibitor

    CBS9106 (SL-801) is a reversible oral CRM1 inhibitor with CRM1 degrading and antitumor activities.
  32. NaV1.7 inhibitor

    GNE-131 is a potent and selective inhibitor of human sodium channel NaV1.7, with an IC50 of 3 nM.
  33. mitochondrial protonophore uncoupler

    BAM 15 is a novel mitochondrial protonophore uncoupler.
  34. TARP γ-8 negative modulator

    AMPA Receptor Modulator-1 is a potent, oral active and selective AMPAR regulatory protein TARP γ-8 negative modulator with a pIC50 of 9.7, more selective over GluA1/γ-2 (pIC50=5).
  35. TRPA1 antagonist

    TRPA1 Antagonist 1 is a methylene phosphate prodrug which converts to its active parent drug, a TRPA1 antagonist with an IC50 of 8 nM.
  36. Transmembrane glutamine flux antagonist

    V-9302 is a competitive antagonist of transmembrane glutamine flux.
  37. AMPA receptor antagonist

    LY3130481 is an AMPA receptor antagonist that is dependent upon transmembrane AMPA receptor regulatory protein (TARP) γ-8, selective inhibits AMPA/TARP γ-8 with an IC50 of 65 nM.
  38. calcium antagonist

    UK51656 is a calcium antagonist with IC50 of 4 nM.
  39. TRPM8 antagonist

    TC-I 2014 (compound 5) is a potent and orally active Benzimidazole-containing transient receptor potential melastatin 8 (TRPM8) antagonist, with IC50 values of 0.8 nM, 3.0 nM and 4.4 nM for canine, human and rat channels respectively.
  40. Fluxametamide is an insecticide with wide spectrum, acts as an antagonist of GABA- and glutamate-gated chloride channels, with IC50 of 1.95 nM and 225 nM for M. domestica GABACls and GluCls.
  41. KCC2 activator

    CLP290 is an orally available activator of the neuron-specific K+-Cl? cotransporter KCC2, displays potential for treatment of a wide range of neurological and psychiatric indications.
  42. KCC2 antagonist

    VU0463271 is a potent KCC2 antagonist, with an IC50 of 61 nM.
  43. TRPV4 antagonist

    GSK3395879 is a selective and orally bioavailable transient receptor potential vanilloid-4 (TRPV4) antagonist with an IC50 of 1 nM for hTRPV4.
  44. Ca2+ antagonist

    Iganidipine is a Ca2+ antagonist.
  45. NCX inhibitor

    SN 6 is a selective Na+/Ca2+ exchanger (NCX) inhibitor, and inhibits 45Ca2+ uptake by NCX1, NCX2, and NCX3, with IC50s of 2.9, 16, and 8.6 μM, respectively.
  46. serotonin-norepinephrine reuptake inhibitor

    Nitroxazepine is a tricyclic antidepressant (TCA) for the treatment of depression. Nitroxazepine acts as a serotonin-norepinephrine reuptake inhibitor.
  47. MRP1/Pgp inhibitor

    Reversan (CBLC4H10) is a potent and nontoxic multidrug resistance-associated protein 1 (MRP1) and P-glycoprotein (Pgp) inhibitor.
  48. calcium channel blocker

    Tiapamil hydrochloride is a calcium channel blocker.
  49. hERG channel activator

    PD-118057 is a human ether-a-go-go-related gene (hERG) channel activator that does not cause hERG blockade.
  50. BKCa channel opener

    BMS-191011 (BMS-A) is an opener of the large-conductance, Ca2++-activated potassium (maxi-K) channel, effective in stroke models.

Items 401-450 of 2532

Page
per page
Set Descending Direction